
Sara Elizabeth Townsley
Examiner (ID: 5080, Phone: (571)270-7672 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1612, 1613 |
| Total Applications | 512 |
| Issued Applications | 97 |
| Pending Applications | 84 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8801910
[patent_doc_number] => 08440182
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => 'Methods and compositions for treating phenylketonuria'
[patent_app_type] => utility
[patent_app_number] => 12/592244
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7689
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12592244
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/592244 | Methods and compositions for treating phenylketonuria | Nov 19, 2009 | Issued |
Array
(
[id] => 6376025
[patent_doc_number] => 20100076083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Treprostinil administration using a metered dose inhaler'
[patent_app_type] => utility
[patent_app_number] => 12/591200
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9617
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076083.pdf
[firstpage_image] =>[orig_patent_app_number] => 12591200
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/591200 | Treprostinil administration by inhalation | Nov 11, 2009 | Issued |
Array
(
[id] => 8951184
[patent_doc_number] => 20130196964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/129407
[patent_app_country] => US
[patent_app_date] => 2009-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88324
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129407
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129407 | HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS | Oct 30, 2009 | Abandoned |
Array
(
[id] => 9375875
[patent_doc_number] => 08680140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms'
[patent_app_type] => utility
[patent_app_number] => 12/606006
[patent_app_country] => US
[patent_app_date] => 2009-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 31
[patent_no_of_words] => 22510
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12606006
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/606006 | Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms | Oct 25, 2009 | Issued |
Array
(
[id] => 7766303
[patent_doc_number] => 20120034270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'S1P Receptors Modulators'
[patent_app_type] => utility
[patent_app_number] => 13/124543
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 65456
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034270.pdf
[firstpage_image] =>[orig_patent_app_number] => 13124543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124543 | S1P receptors modulators | Oct 15, 2009 | Issued |
Array
(
[id] => 6600210
[patent_doc_number] => 20100098654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'TREATMENT OF NEUROBLASTOMA WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN'
[patent_app_type] => utility
[patent_app_number] => 12/579614
[patent_app_country] => US
[patent_app_date] => 2009-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16935
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20100098654.pdf
[firstpage_image] =>[orig_patent_app_number] => 12579614
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/579614 | TREATMENT OF NEUROBLASTOMA WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN | Oct 14, 2009 | Abandoned |
Array
(
[id] => 7744697
[patent_doc_number] => 20120022160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'COMPOSITION FOR EXTERNAL USE ON SKIN'
[patent_app_type] => utility
[patent_app_number] => 13/124114
[patent_app_country] => US
[patent_app_date] => 2009-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5134
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022160.pdf
[firstpage_image] =>[orig_patent_app_number] => 13124114
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124114 | COMPOSITION FOR EXTERNAL USE ON SKIN | Oct 13, 2009 | Abandoned |
Array
(
[id] => 6167292
[patent_doc_number] => 20110195924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'Methods of Inhibiting the Interaction Between S100P and the Receptor for Advanced Glycation End-Products'
[patent_app_type] => utility
[patent_app_number] => 13/122814
[patent_app_country] => US
[patent_app_date] => 2009-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 14584
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195924.pdf
[firstpage_image] =>[orig_patent_app_number] => 13122814
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122814 | Methods of Inhibiting the Interaction Between S100P and the Receptor for Advanced Glycation End-Products | Oct 5, 2009 | Abandoned |
Array
(
[id] => 5368592
[patent_doc_number] => 20090306151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Pharmaceutical preparation containing an angiotensin II receptor antagonist and a calcium channel blocker'
[patent_app_type] => utility
[patent_app_number] => 12/583221
[patent_app_country] => US
[patent_app_date] => 2009-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6738
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306151.pdf
[firstpage_image] =>[orig_patent_app_number] => 12583221
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/583221 | Pharmaceutical preparation containing an angiotensin II receptor antagonist and a calcium channel blocker | Aug 16, 2009 | Abandoned |
Array
(
[id] => 5928848
[patent_doc_number] => 20110038807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING BIPOLAR DISORDER'
[patent_app_type] => utility
[patent_app_number] => 12/541403
[patent_app_country] => US
[patent_app_date] => 2009-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9648
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038807.pdf
[firstpage_image] =>[orig_patent_app_number] => 12541403
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/541403 | COMPOSITIONS AND METHODS FOR TREATING BIPOLAR DISORDER | Aug 13, 2009 | Abandoned |
Array
(
[id] => 5302867
[patent_doc_number] => 20090297519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272'
[patent_app_type] => utility
[patent_app_number] => 12/539914
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9140
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297519.pdf
[firstpage_image] =>[orig_patent_app_number] => 12539914
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/539914 | ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272 | Aug 11, 2009 | Abandoned |
Array
(
[id] => 7487627
[patent_doc_number] => 20110236461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'METHODS FOR STIMULATING CHONDROGENESIS UTILIZING A POTASSIUM CHANNEL INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/058505
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6392
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236461.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058505
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058505 | METHODS FOR STIMULATING CHONDROGENESIS UTILIZING A POTASSIUM CHANNEL INHIBITOR | Aug 11, 2009 | Abandoned |
Array
(
[id] => 6195576
[patent_doc_number] => 20110027331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'AN IMPLANTABLE DRUG DEPOT HAVING A REVERSIBLE PHASE TRANSITION MATERIAL FOR TREATMENT OF PAIN AND/OR INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 12/511524
[patent_app_country] => US
[patent_app_date] => 2009-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23393
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027331.pdf
[firstpage_image] =>[orig_patent_app_number] => 12511524
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/511524 | AN IMPLANTABLE DRUG DEPOT HAVING A REVERSIBLE PHASE TRANSITION MATERIAL FOR TREATMENT OF PAIN AND/OR INFLAMMATION | Jul 28, 2009 | Abandoned |
Array
(
[id] => 5959946
[patent_doc_number] => 20110184333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'PHOTOLABILE CAGED TRANSITION METAL COMPLEXES AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/055788
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10041
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20110184333.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055788
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055788 | Photolabile caged transition metal complexes and methods of using the same | Jul 22, 2009 | Issued |
Array
(
[id] => 6349088
[patent_doc_number] => 20100021524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'PIMETHIXENE DERIVATIVES FOR PROMOTING BONE GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/505713
[patent_app_country] => US
[patent_app_date] => 2009-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12687
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021524.pdf
[firstpage_image] =>[orig_patent_app_number] => 12505713
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/505713 | PIMETHIXENE DERIVATIVES FOR PROMOTING BONE GROWTH | Jul 19, 2009 | Abandoned |
Array
(
[id] => 5458697
[patent_doc_number] => 20090258849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'NITROOXY DERIVATIVES OF GLUCOCORTICOIDS'
[patent_app_type] => utility
[patent_app_number] => 12/492359
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10757
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258849.pdf
[firstpage_image] =>[orig_patent_app_number] => 12492359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/492359 | NITROOXY DERIVATIVES OF GLUCOCORTICOIDS | Jun 25, 2009 | Abandoned |
Array
(
[id] => 5496365
[patent_doc_number] => 20090264393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'NITROOXY DERIVATIVES OF GLUCOCORTICOIDS'
[patent_app_type] => utility
[patent_app_number] => 12/492337
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10757
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264393.pdf
[firstpage_image] =>[orig_patent_app_number] => 12492337
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/492337 | NITROOXY DERIVATIVES OF GLUCOCORTICOIDS | Jun 25, 2009 | Abandoned |
Array
(
[id] => 5496366
[patent_doc_number] => 20090264394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'NITROOXY DERIVATIVES OF GLUCOCORTICOIDS'
[patent_app_type] => utility
[patent_app_number] => 12/492404
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10757
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264394.pdf
[firstpage_image] =>[orig_patent_app_number] => 12492404
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/492404 | NITROOXY DERIVATIVES OF GLUCOCORTICOIDS | Jun 25, 2009 | Abandoned |
Array
(
[id] => 6629475
[patent_doc_number] => 20100004275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'AGENT FOR SUPPRESSING DEVELOPMENT OF TOLERANCE TO NARCOTIC ANALGESICS'
[patent_app_type] => utility
[patent_app_number] => 12/480387
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3105
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20100004275.pdf
[firstpage_image] =>[orig_patent_app_number] => 12480387
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/480387 | AGENT FOR SUPPRESSING DEVELOPMENT OF TOLERANCE TO NARCOTIC ANALGESICS | Jun 7, 2009 | Abandoned |
Array
(
[id] => 5534229
[patent_doc_number] => 20090234017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'TREATING SKIN DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/468716
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3138
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20090234017.pdf
[firstpage_image] =>[orig_patent_app_number] => 12468716
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/468716 | TREATING SKIN DISORDERS | May 18, 2009 | Abandoned |